MedPage Today on MSN
CAR-T Immune Toxicity Linked to Non-Relapse Mortality Risk in Myeloma
Chimeric antigen receptor (CAR) T-cell therapy-associated immune-related adverse events (CirAEs) were associated with a high ...
Higher levels of CD4-positive naïve T cells in patients receiving CAR T-cell therapy for multiple myeloma are associated with ...
This article is based on a poster originally authored by Weiping Sun, Xing Zhang, Zhaolu Yan, Chen Yu, Spencer Chiang, and Tianfu Zhang. Immunotherapy is an advanced and widely used treatment due to ...
Major histocompatibility complex class II (MHC-II) molecules play a critical, yet historically overlooked, role in tumor immunity. This review synthesizes emerging mechanistic evidence showing that ...
A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...
MedPage Today on MSN
Autoimmune anemia is the latest condition found responsive to CAR-T therapy
Eleven patients with refractory autoimmune hemolytic anemia (AIHA) were all brought into drug-free remission with CAR T-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback